The progression from hypertension to congestive heart failure - PubMed (original) (raw)
. 1996 May;275(20):1557-62.
Affiliations
- PMID: 8622246
The progression from hypertension to congestive heart failure
D Levy et al. JAMA. 1996 May.
Abstract
Objectives: - To study the relative and population-attributable risks of hypertension for the development of congestive heart failure (CHF), to assess the time course of progression from hypertension to CHF, and to identify risk factors that contribute to the development of overt heart failure in hypertensive subjects.
Design: - Inception cohort study.
Setting: - General community.
Participants: - Original Framingham Heart Study and Framingham Offspring Study participants aged 40 to 89 years and free of CHF. To reflect more contemporary experience, the starting point of this study was January 1, 1970.
Exposure measures: - Hypertension (blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic or current use of medications for treatment of high blood pressure) and other potential CHF risk factors were assessed at periodic clinic examinations.
Outcome measure: - The development of CHF.
Results: - A total of 5143 eligible subjects contributed 72422 person-years of observation. During up to 20.1 years of follow-up (mean, 14.1 years), there were 392 new cases of heart failure; in 91% (357/392), hypertension antedated the development of heart failure. Adjusting for age and heart failure risk factors in proportional hazards regression models, the hazard for developing heart failure in hypertensive compared with normotensive subjects was about 2-fold in men and 3-fold in women. Multivariable analyses revealed that hypertension had a high population-attributable risk for CHF, accounting for 39% of cases in men and 59% in women. Among hypertensive subjects, myocardial infarction, diabetes, left ventricular hypertrophy, and valvular heart disease were predictive of increased risk for CHF in both sexes. Survival following the onset of hypertensive CHF was bleak; only 24% of men and 31% of women survived 5 years.
Conclusions: - Hypertension was the most common risk factor for CHF, and it contributed a large proportion of heart failure cases in this population-based sample. Preventive strategies directed toward earlier and more aggressive blood pressure control are likely to offer the greatest promise for reducing the incidence of CHF and its associated mortality.
Comment in
- High blood pressure: some answers, new questions, continuing challenges.
Lenfant C. Lenfant C. JAMA. 1996 May 22-29;275(20):1604-6. doi: 10.1001/jama.275.20.1604. JAMA. 1996. PMID: 8622253 No abstract available.
Similar articles
- Incidence and epidemiology of heart failure.
Kannel WB. Kannel WB. Heart Fail Rev. 2000 Jun;5(2):167-73. doi: 10.1023/A:1009884820941. Heart Fail Rev. 2000. PMID: 16228142 Review. - Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.
Haider AW, Larson MG, Franklin SS, Levy D; Framingham Heart Study. Haider AW, et al. Ann Intern Med. 2003 Jan 7;138(1):10-6. doi: 10.7326/0003-4819-138-1-200301070-00006. Ann Intern Med. 2003. PMID: 12513039 - Diurnal blood pressure pattern and risk of congestive heart failure.
Ingelsson E, Björklund-Bodegård K, Lind L, Arnlöv J, Sundström J. Ingelsson E, et al. JAMA. 2006 Jun 28;295(24):2859-66. doi: 10.1001/jama.295.24.2859. JAMA. 2006. PMID: 16804152 - Natural history of asymptomatic left ventricular systolic dysfunction in the community.
Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Wang TJ, et al. Circulation. 2003 Aug 26;108(8):977-82. doi: 10.1161/01.CIR.0000085166.44904.79. Epub 2003 Aug 11. Circulation. 2003. PMID: 12912813 - [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
Nogueira JB. Nogueira JB. Rev Port Cardiol. 1999 Jun;18(6):635-46. Rev Port Cardiol. 1999. PMID: 10422461 Review. Portuguese.
Cited by
- Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.
Chimura M, Wang X, Jhund PS, Henderson AD, Claggett BL, Desai AS, Fonseca C, Goncalvesova E, Katova T, Mueller K, Glasauer A, Rohwedder K, Viswanathan P, Nodari S, Lam CSP, Saldarriaga CI, Senni M, Sharma K, Voors AA, Zannad F, Pitt B, Vardeny O, Vaduganathan M, Solomon SD, McMurray JJV. Chimura M, et al. JAMA Cardiol. 2024 Nov 17:e244613. doi: 10.1001/jamacardio.2024.4613. Online ahead of print. JAMA Cardiol. 2024. PMID: 39550721 Free PMC article. - Prognosis of apparent treatment-resistant hypertension and poor adherence: a nationwide cohort study.
Lee CJ, Lee H, Seo J, Hwang J, Kang D, Park SH, Hwang JT, Park JH, Park S. Lee CJ, et al. Hypertens Res. 2024 Nov 14. doi: 10.1038/s41440-024-01988-x. Online ahead of print. Hypertens Res. 2024. PMID: 39543414 - Noninvasive biometric monitoring technologies for patients with heart failure.
Arriola-Montenegro J, Mutirangura P, Akram H, Tsangaris A, Koukousaki D, Tschida M, Money J, Kosmopoulos M, Harata M, Hughes A, Toth A, Alexy T. Arriola-Montenegro J, et al. Heart Fail Rev. 2024 Oct 22. doi: 10.1007/s10741-024-10441-7. Online ahead of print. Heart Fail Rev. 2024. PMID: 39436486 Review. - The Impact of Sacubitril/Valsartan on Heart Failure Patient with Reduced Left Ventricular Ejection Fraction: Single Center Retrospective Study in Saudi Arabia.
Al Raddadi S, Almutairi M, AlAamer K, Alsalman A, Albalawi M, Almeshary M, Badreldin HA, Almodaimegh H. Al Raddadi S, et al. Drug Healthc Patient Saf. 2024 Sep 30;16:117-124. doi: 10.2147/DHPS.S471867. eCollection 2024. Drug Healthc Patient Saf. 2024. PMID: 39372487 Free PMC article. - Impact of first-line antihypertensive drug class and intensity on NT-proBNP improvement and cardiovascular outcomes among hypertensive patients with pre-heart failure: findings from SPRINT trial.
Wang L, Yi J, Wang W, Zhou Z, Liu J, Zhang H, Li Y, Ren X, Lu J, Zheng X. Wang L, et al. Hypertens Res. 2024 Oct 2. doi: 10.1038/s41440-024-01873-7. Online ahead of print. Hypertens Res. 2024. PMID: 39358594
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical